Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
1 093,811 096,521 100,221 091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
1 254,811 253,011 253,871 226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
1 761,111 764,271 766,881 744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
3 211,833 227,213 268,383 226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
1 474,521 479,031 481,041 466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
2 392,122 396,952 421,222 382,32
Q1 2026 earnings • in 4 days
See details
GUD:TSE
Knight Therapeutics Inc
CAD 7,55
+0,67%
(+0,050) 1D
1 Mei, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for GUD...
Open
CAD 7,52
High
CAD 7,55
Low
CAD 7,44
Mkt. cap
741,80 m
Avg. vol.
90,49 k
Volume
33,44 k
52-wk high
CAD 7,74
52-wk low
CAD 5,50
EPS
-CAD 0,05
Beta
-0,05
Shares outstanding
98,03 m
No. of employees
830
News stories
From sources across the web
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Kanada
SectorPharmaceutical industry
Next call oor 4 dae
Do. 7 Mei, 08:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (0,01 est.)CAD
Revenue / Estimate
-/ (114,06 m est.)CAD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
88,08 m
107,36 m
121,55 m
133,11 m
Cost of goods sold
53,21 m
62,53 m
65,74 m
68,38 m
Cost of revenue
53,21 m
62,53 m
65,74 m
68,38 m
Research and development expenses
4,79 m
6,28 m
8,69 m
9,22 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,14 m
31,49 m
31,02 m
35,45 m
Operating expense
40,40 m
48,50 m
55,16 m
58,51 m
Total operating expenses
93,61 m
111,03 m
120,90 m
126,90 m
Operating income
-5,54 m
-3,67 m
646,00 k
6,21 m
Other non operating income
-140,00 k
-2,19 m
-271,00 k
329,00 k
EBT including unusual items
-399,00 k
-15,61 m
-1,92 m
11,22 m
EBT excluding unusual items
-28,00 k
-10,77 m
2,24 m
1,57 m
Income tax expense
-2,58 m
-2,99 m
1,87 m
2,37 m
Effective tax rate
647,62%
19,14%
-97,76%
21,12%
Other operating expenses
-
-
-
-
Net income
2,18 m
-12,62 m
-3,79 m
8,85 m
Net profit margin
2,48%
-11,76%
-3,12%
6,65%
Earnings per share
0,03
-0,09
-0,02
0,10
Interest and investment income
1,85 m
2,03 m
1,11 m
1,22 m
Interest expense
-1,76 m
-2,37 m
-2,37 m
-3,92 m
Net interest expenses
98,00 k
-348,00 k
-1,26 m
-2,70 m
Depreciation and amortization charges
-
-
-
-
EBITDA
6,05 m
8,47 m
18,41 m
16,47 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more